Visacor

Land: Nya Zeeland

Språk: engelska

Källa: Medsafe (Medicines Safety Authority)

Aktiva substanser:

Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin

Tillgänglig från:

AstraZeneca Limited

INN (International namn):

Rosuvastatin calcium 10.4 mg (= 10 mg rosuvastatin)

Dos:

10 mg

Läkemedelsform:

Film coated tablet

Sammansättning:

Active: Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Enheter i paketet:

Blister pack, Al/Al foil, 7 tablets

Klass:

Prescription

Receptbelagda typ:

Prescription

Tillverkad av:

IPR Pharmaceuticals Inc

Terapeutiska indikationer:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Produktsammanfattning:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 7 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Tillstånd datum:

2009-07-31